FXN and obesity due to melanocortin 4 receptor deficiency: FXN (Figure 1a), a seaweed carotenoid, has gained popularity recently due to its antioxidant properties, and is therefore considered a protective agent that could decrease the oxidative-inflammatory status associated with body weight gain, and it is being applied in the treatment of the various diseases triggered by obesity [84,85].